We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+14.01%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
-$554M
Cap. Flow
-$798M
Cap. Flow %
-22.13%
Top 10 Hldgs %
9.27%
Holding
2,296
New
622
Increased
390
Reduced
675
Closed
586

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Consumer Discretionary 14.11%
3 Healthcare 13.6%
4 Industrials 12.95%
5 Financials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFUN
1651
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$65K ﹤0.01%
+2,286
New +$47.4K
STEX
1652
Streamex Corp
STEX
$83M
$64K ﹤0.01%
+1,074
New +$72.6K
IMDX
1653
Insight Molecular Diagnostics
IMDX
$156M
$64K ﹤0.01%
+1,413
New +$51K
AFI
1654
DELISTED
Armstrong Flooring, Inc.
AFI
$64K ﹤0.01%
15,047
-27,993
-65% -$137K
PACQW
1655
DELISTED
Pure Acquisition Corp. Warrant
PACQW
$63K ﹤0.01%
64,206
-798,294
-93% -$856K
SES
1656
DELISTED
Synthesis Energy Systems Inc.
SES
$63K ﹤0.01%
+10,987
New +$66.7K
KNDI
1657
Kandi Technologies Group
KNDI
$65.5M
$62K ﹤0.01%
+13,076
New +$63.7K
ABUS icon
1658
Arbutus Biopharma
ABUS
$915M
$61K ﹤0.01%
+22,051
New +$35.7K
VNRX icon
1659
VolitionRx Ltd
VNRX
$9.34M
$58K ﹤0.01%
+613
New +$63.6K
VATE icon
1660
INNOVATE Corp
VATE
$165M
$57K ﹤0.01%
2,630
-6,859
-72% -$151K
ZSAN
1661
DELISTED
Zosano Pharma Corporation
ZSAN
$57K ﹤0.01%
+1,075
New +$66.3K
PFSW
1662
DELISTED
PFSweb, Inc.
PFSW
$56K ﹤0.01%
14,560
-39,431
-73% -$134K
LAC
1663
DELISTED
Lithium Americas Corp. Common Shares
LAC
$56K ﹤0.01%
+17,755
New +$53.9K
ACRS icon
1664
Aclaris Therapeutics
ACRS
$869M
$52K ﹤0.01%
+27,599
New +$45.7K
CBAY
1665
DELISTED
Cymabay Therapeutics
CBAY
$51K ﹤0.01%
+25,779
New +$96.8K
GEVO icon
1666
Gevo
GEVO
$382M
$50K ﹤0.01%
+21,756
New +$55.5K
CNSY
1667
Cerenome, Inc. Common Stock
CNSY
$26.4M
$50K ﹤0.01%
+55
New +$50.4K
YCBD icon
1668
cbdMD
YCBD
$5.93M
$50K ﹤0.01%
+61
New +$73.2K
CIH
1669
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$50K ﹤0.01%
13,754
+2,406
+21% +$8.43K
CORV
1670
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$48K ﹤0.01%
+116,653
New +$194K
XOG
1671
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$46K ﹤0.01%
+21,770
New +$44.5K
SNAXW
1672
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$45K ﹤0.01%
225,450
-264,550
-54% -$57K
VUZI icon
1673
Vuzix
VUZI
$224M
$44K ﹤0.01%
+21,792
New +$49.3K
SER icon
1674
Serina Therapeutics
SER
$36M
$41K ﹤0.01%
648
-22
-3% -$1.19K
GRNVR
1675
DELISTED
GreenVision Acquisition Corp Rights
GRNVR
$40K ﹤0.01%
+222,705
New +$41.3K

Similar funds

Oxford Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Oxford Asset Management held 2,296 positions worth $3.6B, down 13% from $4.16B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Oxford Asset Management withdrew a net $798M in Q4 2019, closing 586 positions and reducing 675 holdings. Its most notable exit was Medidata Solutions, Inc., an estimated $48.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in WABCO HOLDINGS INC. worth $42M.

  • Oxford Asset Management's largest Q4 2019 buy was WABCO HOLDINGS INC.: 310,063 shares worth $42M.
  • Oxford Asset Management added most to China Biologic Products Holdings, Inc. in Q4 2019, an estimated $16.2M increase.
  • Oxford Asset Management's biggest Q4 2019 reduction was Intuit, cutting an estimated $22.5M.
  • Oxford Asset Management fully exited Medidata Solutions, Inc. in Q4 2019, selling an estimated $48.1M.
  • Oxford Asset Management's ten largest holdings make up 9.3% of its $3.6B portfolio in Q4 2019.
  • Oxford Asset Management opened 622 new positions and closed 586 in Q4 2019.
  • Oxford Asset Management's portfolio value fell 13% quarter-over-quarter to $3.6B.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.